Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia | Zendy

Maurizia Lanza | Zendy; Giorgio Emanuele Polistina | Zendy; Pasquale Imitazione | Zendy; Anna Annunziata | Zendy; Valentina Di Spirito | Zendy; Novella Carannante | Zendy; Giuseppe Fiorentino | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia

Author(s) -

Maurizia Lanza,

Giorgio Emanuele Polistina,

Pasquale Imitazione,

Anna Annunziata,

Valentina Di Spirito,

Novella Carannante,

Giuseppe Fiorentino

Publication year - 2020

Publication title -

idcases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.319

H-Index - 13

ISSN - 2214-2509

DOI - 10.1016/j.idcr.2020.e00794

Subject(s) - medicine , covid-19 , pneumonia , intravenous immunoglobulin therapy , antibody , intensive care medicine , respiratory failure , intravenous immunoglobulins , immunoglobulin g , persistence (discontinuity) , immunology , virology , infectious disease (medical specialty) , disease , outbreak , geotechnical engineering , engineering

We describe a 42-year old woman, admitted to our Department after 15 days of persistence of respiratory failure and treated with infusion of intravenous immunoglobulin with a successful outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research